The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Cellares, an first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing,...
read more
Bruker Corporation signed a definitive agreement to acquire PhenomeX for $1.00 per share in an all-cash transaction.
read more
Astellas Pharma and Poseida Therapeutics announced an investment to support Poseida's commitment to redefining cancer cell therapy.
read more
Wednesday, August 02, 2023
Kala Pharmaceuticals announced that it will change its name to KALA BIO, effective August 2, 2023,
read more
Astellas Pharma announced the European Medicines Agency (EMA) accepted the marketing authorization application (MAA) for zolbetuximab, a first-in-...
read more
BeiGene announced the FDA accepted for review the Company’s supplemental new drug application (sNDA) for BRUKINSA® (zanubrutinib) in combination with ...
read more
Longeveron announced the appointment of Nataliya Agafonova, M. D., as the Company’s Chief Medical Officer (CMO), effective July 1, 2023.
read more
Immunome, a biopharmaceutical company utilizing a proprietary human memory B-cell platform to discover and develop antibody therapeutics to improve ...
read more
Skyline Therapeutics, an innovation-driven gene therapy company committed to developing unique and novel solutions for rare and severe diseases, ...
read more
Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumor and lymphoma treatment, announced the official ...
read more
Donaldson Company, Inc., a worldwide provider of filtration products and solutions announced the acquisition of Univercells Technologies, a global ...
read more
Synthego announced a partnership with ATCC to provide researchers with an extensive collection of mammalian and mouse cell lines for gene editing ...
read more
Curia has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables ...
read more
AstraZeneca has entered into a collaboration, and exclusive option and license agreement with Quell Therapeutics to develop multiple engineered T-...
read more
Modality Solutions and CSafe announced a strategic partnership to provide a next-generation cold chain solution for cell and gene therapies (CGTs).
read more